Kinetic studies on the reactions of Y-phenyl chloroformates with X-pyridines in acetonitrile are
carried out at 25.0 °C. Both the Hammett and Brönsted plots are linear with enhanced substituent
constants, σp
-, and basicities, pK
a
-, for strong para π-acceptor X-substituents, p-CN and p-CH3CO.
This indicates that the electron-rich formate (O−C−O) moiety overlaps with the pyridine ring
π-system enabling, through conjugation with the para π-acceptors, the rate-limiting formation of
a tetrahedral intermediate. The difference in the aminolysis mechanism between methyl, II, and
phenyl chloroformate, III, is attributed to the much stronger electron-donating polarizability effect
of C6H5 than of CH3. The proposed mechanism is supported by a relatively small βX (≅0.3) and by
the lower ΔH
⧧ (6.7 kcal mol-1) and ΔS
⧧ (−44 eu) values for a stronger donor Y (Y = p-CH3O) coupled
with a stronger para π-acceptor (X = p-CN) in pyridine.
Kinetic studies of the pyridinolysis (XC(5)H(4)N) of aryl dithioacetates (CH(3)C(=S)SC(6)H(4)Z) are carried out in acetonitrile at 60.0 degrees C. A biphasic Brönsted plot is obtained with a change in slope from a large value (beta(X) congruent with 0.9) to a small value (beta(X) congruent with 0.4) at pK(a) degrees = 5.2, which is attributed to a change in the rate-limiting step from breakdown to formation of a zwitterionic tetrahedral intermediate, T(+/-), in the reaction path as the basicity of the pyridine nucleophile increases. A clear-cut change in the cross-interaction constants rho(XZ) from a large positive value (rho(XZ) = +1.34) to a small negative value (rho(XZ) = -0.15) supports the mechanistic change proposed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.